• ONX-0914 (PR-957) in Autoimmune Disease Models: Applied Work

  2026-05-12

  ONX-0914 (PR-957) enables highly selective immunoproteasome inhibition, giving researchers superior control over cytokine blockade in autoimmune disease models. This article delivers actionable protocol enhancements, troubleshooting strategies, and unique cross-study insights that set ONX-0914 apart for translational immunology research.

• Talabostat Mesylate: Precision DPP4 and FAP Inhibition Workf

  2026-05-11

  Talabostat mesylate (PT-100) empowers cancer and immunology researchers to dissect tumor microenvironment dynamics and T-cell immunity with unmatched specificity. This guide demystifies experimental design, troubleshooting, and data-driven protocol refinement for leveraging Talabostat in both in vitro and in vivo systems.

• SCUBE3 Antibody Targeting: Blocking Oncogenic Signaling and

  2026-05-11

  This study identifies secretory SCUBE3 as a critical driver of tumor growth, therapy resistance, and immune suppression across diverse cancer types. Antibody-mediated targeting of SCUBE3 disrupts oncogenic signaling and restores antitumor immunity, suggesting a promising pan-cancer therapeutic strategy.

• Cefotaxime in Antimicrobial Resistance: Gene Dynamics & Assa

  2026-05-10

  Explore how Cefotaxime, a third-generation cephalosporin antibiotic, empowers advanced antimicrobial resistance research by bridging genetic transmission dynamics with rigorous assay design. Discover unique insights beyond standard overviews, integrating multidrug resistance epidemiology and practical protocol recommendations.

• SU5416 (Semaxanib): Precision VEGFR2 Inhibition in Cancer an

  2026-05-09

  SU5416 (Semaxanib) stands out as a dual-action VEGFR2 inhibitor and AHR agonist, enabling high-fidelity angiogenesis inhibition in both cancer and pulmonary hypertension models. This guide synthesizes workflow enhancements, troubleshooting, and context-driven protocol optimization, directly informed by benchmark studies and translational workflows.

• Latrunculin A (SKU B7555): Precision in Actin Cytoskeleton D

  2026-05-09

  This article addresses real laboratory challenges in actin cytoskeleton disruption and cell-based assays, demonstrating how Latrunculin A (SKU B7555) from APExBIO offers reproducible, evidence-backed solutions. Integrating scenario-driven Q&A and published data, it guides biomedical researchers in optimizing assay reliability and interpreting mechanistic outcomes using this reversible inhibitor of actin assembly.

• TP53-Dependent Antitumor Effects of DHODH Inhibition in NPC

  2026-05-08

  Dong et al. present a comprehensive study elucidating the TP53-dependent antitumor mechanism of DHODH inhibition in nasopharyngeal carcinoma (NPC). Their findings highlight the role of nucleic acid metabolism reprogramming in NPC progression and identify DHODH as a promising therapeutic target with particular relevance for tumors harboring wild-type TP53.

• XAV-939: Applied Protocols for Wnt Pathway and Fibrosis Rese

  2026-05-07

  XAV-939 (NVP-XAV939) by APExBIO is a premier tankyrase 1/2 inhibitor, empowering precise modulation of Wnt/β-catenin signaling in cancer, fibrosis, and osteogenic differentiation workflows. This article offers hands-on protocol guidance, advanced use-cases, and troubleshooting insights, translating cutting-edge research findings into practical optimization steps for translational scientists.

• 3X (DYKDDDDK) Peptide: Structural Precision for Affinity Pur

  2026-05-07

  Explore how the 3X (DYKDDDDK) Peptide enables high-fidelity affinity purification of FLAG-tagged proteins. Delve into the structural, mechanistic, and assay-specific factors that elevate its performance beyond conventional tags.

• Minoxidil Sulphate in Renal Vasculature: Research Protocols

  2026-05-06

  Explore Minoxidil sulphate as a pivotal tool in vascular biology and renal blood flow research. This article uniquely focuses on its application in dissecting potassium channel function in the renal vasculature, offering advanced protocols and a critical analysis of translational impacts.

• Spermine Tetrahydrochloride: Precision Crosslinking & Protei

  2026-05-06

  Spermine tetrahydrochloride empowers researchers to stabilize protoplasts, enhance protein crystallization, and crosslink polyphosphazene nanoparticles with unmatched reproducibility. Leveraging data-driven protocols and troubleshooting insights, this article translates bench-top experimental workflows into reliable results across cell biology, protein biochemistry, and nanoparticle engineering.

• Salinomycin as a Polyether Ionophore: Mechanistic Insights f

  2026-05-05

  Explore how Salinomycin, a polyether ionophore antibiotic, advances hepatocellular carcinoma research with unique mechanistic insights and actionable protocols. This article goes beyond existing resources by dissecting ion transport, toxicity, and translational assay decisions for precision cancer modeling.

• NSAID Cytotoxicity in Canine Osteosarcoma: Insights for Bone

  2026-05-05

  This study systematically compared the in vitro cytotoxic effects of deracoxib and piroxicam on canine osteosarcoma cell lines, revealing that deracoxib achieved cytotoxicity at lower concentrations than piroxicam and selectively spared fibroblasts. These findings refine our understanding of NSAID utility as antiproliferative agents in tumor cell lines and inform preclinical assay design for bone metabolism and oncology research.

• METTL14 Modulates Colitis via m6A and the DHRS4-AS1/miR-206/

  2026-05-04

  This study elucidates how METTL14-mediated m6A modification regulates inflammation in ulcerative colitis through the DHRS4-AS1/miR-206/A3AR axis. The findings reveal a critical epigenetic mechanism underlying colonic inflammatory injury, offering new targets for therapeutic intervention and experimental design in methylation-dependent disease models.

• 8-Chloroadenosine: Mechanistic Insights for lncRNA and RNA D

  2026-05-04

  Explore the advanced utility of 8-Chloroadenosine as a nucleoside analog in dissecting lncRNA-mediated transcriptional regulation and RNA metabolism. This in-depth guide uniquely connects molecular mechanism with high-impact cancer research workflows.

444 records 18/30 page Previous Next First page 上5页 1617181920 下5页 Last page